Oxytocin Market: Global Industry Analysis and Forecast (2024-2030) by Indication, Distribution Channel, and Region.

Oxytocin Market Definition & Overview:

The neuropeptide hormone oxytocin has sparked a spike in market interest due to its pivotal role in human evolution. The peptide hormone has a role in a variety of physiological functions. It helps in birth, lactation, and maternal behaviour, among other things. For example, the oxytocin market has grown as a result of research into broadening oxytocin's roles beyond initiating birth.

The race for the global oxytocin market gathered up speed significantly. This is primarily owing to scientists looking into the significance of oxytocin in human well-being, considering how important it may be in influencing social behaviours and modifying emotions in humans and other species. Exogenously delivered oxytocin has been shown to improve a variety of social behaviours. The healthcare sector, in particular, is banking on oxytocin's enormous potential in mental illnesses, as a cancer biomarker, and in the development of a wide variety of treatments, including analgesics.

To get more Insights: Request Free Sample Report

Oxytocin Market Dynamics:

The need for synthetic oxytocin has risen in response to an increase in C-sections, which has been aided by FDA-approved formulations. Human illness research has been a leading indicator of the oxytocin market's growing revenue potential. In recent years, a slew of neuroscientific studies has looked into new avenues in novel treatment techniques for mental diseases, with oxytocin assisting in the discovery of new therapeutic targets. As a result, the oxytocin market has opened up new income opportunities in autism, depression, schizophrenia, borderline personality disorder, and social anxiety disorders.

One of the main factors driving the oxytocin market is a growing interest in social cognition. A rising number of placebo trials is accelerating market progress. Advances in neuroimaging technology have fuelled a lot of progress in this field. A variety of animal research has broadened the oxytocin market's possibilities. In addition, the rising number of induced births in developing countries has boosted the demand for hospitals and institutional delivery in many regions of the world. In the forecast period, advances in the neurobiology of oxytocin effects will increase revenue potential in the oxytocin market.

Oxytocin Market Segment Analysis:

By Indication, PPH (postpartum haemorrhage) is expected to be favourable in the oxytocin market during the forecast period. Postpartum haemorrhage affects around 3-5 percent of obstetric patients, accounting for a quarter of all maternal fatalities worldwide. As a result, efforts are being made to avoid such deaths, offering a substantial boost to postpartum haemorrhage management. Antepartum haemorrhage (APH) is also gaining pace, with an incremental potential worth US$ 13.4 million expected by 2030. Antepartum haemorrhage puts both the mother and the foetus in danger, therefore it's critical to treat it, pushing drug companies to come up with new formulations.

By Distribution Channel, The major point of contact for obtaining prescription oxytocin-controlling medications is hospital pharmacies. Hospital pharmacies sell more than three out of every five pharmaceuticals, owing to a higher likelihood of availability than alternative distribution channels. However, as a result of the rapid growth of virtual market spaces in reaction to the coronavirus epidemic, online pharmacies are gaining traction. To meet the rising demand for oxytocin formulations, platforms like CVS Pharmacies and Walgreens have improved their web presence.

Oxytocin Market Regional Insights:

In 2023, the North American oxytocin market reached $5 billion in sales, owing to increased rates of delivery and pregnancy-related problems. Pregnant women with pre-existing diseases are becoming more common, according to Blue Cross Blue Shield. In addition, the number of women who had both delivery and pregnancy problems increased by more than 31% from 2014 to 2018. Pre-eclampsia (19%) and gestational diabetes (16.6%) are also included as the leading causes of pregnancy complications, according to the survey. Pharmaceutical producers in the United States are responding to these developments by increasing synthetic oxytocin manufacturing.

By 2027, the European oxytocin market is expected to grow at a rate of nearly 8% in terms of value. Promising developments in maternity care have aided in the growth of oxytocin product sales across the continent. The maternal mortality rate fell roughly in half between 2000 and 2015, from 33 to 16 deaths per 100,000 live births. Women of 'non-western' ancestry, on the other hand, have a 60 percent greater death rate than their European counterparts.

The objective of the report is to present a comprehensive analysis of the Oxytocin Market to the stakeholders in the industry. The report provides trends that are most dominant in the Oxytocin Market and how these trends will influence new business investments and market development throughout the forecast period. The report also aids in the comprehension of the market dynamics and competitive structure of the market by analyzing market leaders, market followers, and regional players.

The qualitative and quantitative data provided in the Oxytocin Market report is to help understand which market segments, regions are expected to grow at higher rates, factors affecting the market, and key opportunity areas, which will drive the industry and market growth through the forecast period. The report also includes the competitive landscape of key players in the industry along with their recent developments in the Oxytocin Market. The report studies factors such as company size, market share, market growth, revenue, production volume, and profits of the key players in the market.

The report provides Porter's Five Force Model, which helps in designing the business strategies in the market. The report helps in identifying how many rivals are existing, who they are, and how their product quality is in the Market. The report also analyses if the Oxytocin Market is easy for a new player to gain a foothold in the market, do they enter or exit the market regularly if the market is dominated by a few players, etc.

Oxytocin Market Scope:

Oxytocin Market Players:

• Pfizer Inc. (United States)
• Novartis AG (Switzerland)
• Fresenius Kabi LLC (United States)
• Hikma Pharmaceuticals PLC (United Kingdom)
• Endo International Plc. (Par Sterile Products, LLC) (Ireland)
• Teva Pharmaceuticals Ltd. (Jerusalem)
• Mylan N.V. (United States)
• Wockhardt Ltd. (Mumbai)
• Sun Pharmaceutical Industries Ltd. (Mumbai)
• Yuhan Corporation (South Korea)